CMS SEEKS COMMENT ON FOUR PAYMENT SCHEMES

Why This Topic Matters

It helps readers understand how proposed changes to Medicare drug payment methodology could affect reimbursement, budgeting, and market behavior, while providing context for legislative and regulatory alternatives under consideration.

Article Sections

1. Overview of CMS payment alternatives

   Introduces the policy issue and explains why CMS is linking changes in practice expense payments with changes in drug payment methodology.

2. First alternative

   Describes a payment approach tied to amounts paid in comparable circumstances and summarizes the estimated fiscal impact.

3. Second alternative and Senate approach

   Covers a benchmark-based reimbursement method, related treatment of newer drugs, and the Senate proposal discussed alongside it.

4. Third alternative

   Explains a market-price-based approach, the role of market monitoring, and the use of fallback pricing when market data are unavailable.

5. Fourth alternative and House approach

   Summarizes a bidding-based or benchmark-based framework and compares it with the House proposal, including projected savings estimates.